| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | costamere | 2.29e-05 | 22 | 53 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | nuclear body | NELFE TCF20 YLPM1 NUFIP2 ACIN1 ZFHX3 CMYA5 TERF2 TP53 EFTUD2 | 7.74e-05 | 903 | 53 | 10 | GO:0016604 |
| HumanPheno | Decreased eosinophil count | 3.07e-06 | 9 | 18 | 3 | HP:0031891 | |
| Domain | CS | 7.30e-04 | 14 | 54 | 2 | PF04969 | |
| Domain | Znf_FYVE_PHD | 8.58e-04 | 147 | 54 | 4 | IPR011011 | |
| Domain | PDZ | 9.48e-04 | 151 | 54 | 4 | PS50106 | |
| Domain | CS_dom | 9.59e-04 | 16 | 54 | 2 | IPR007052 | |
| Domain | CS | 9.59e-04 | 16 | 54 | 2 | PS51203 | |
| Domain | PDZ | 9.72e-04 | 152 | 54 | 4 | IPR001478 | |
| Domain | HSP70_2 | 1.09e-03 | 17 | 54 | 2 | PS00329 | |
| Domain | HSP70_3 | 1.09e-03 | 17 | 54 | 2 | PS01036 | |
| Domain | HSP70_1 | 1.09e-03 | 17 | 54 | 2 | PS00297 | |
| Domain | Hsp_70_fam | 1.22e-03 | 18 | 54 | 2 | IPR013126 | |
| Domain | EPHD | 1.83e-03 | 22 | 54 | 2 | PS51805 | |
| Domain | SH3_2 | 1.97e-03 | 86 | 54 | 3 | IPR011511 | |
| Domain | SH3_2 | 1.97e-03 | 86 | 54 | 3 | PF07653 | |
| Domain | - | 2.00e-03 | 23 | 54 | 2 | 2.60.40.790 | |
| Domain | HSP20-like_chaperone | 2.55e-03 | 26 | 54 | 2 | IPR008978 | |
| Domain | C2 | 6.44e-03 | 131 | 54 | 3 | PF00168 | |
| Domain | C2 | 7.29e-03 | 137 | 54 | 3 | SM00239 | |
| Domain | PDZ | 7.89e-03 | 141 | 54 | 3 | PF00595 | |
| Domain | C2 | 8.04e-03 | 142 | 54 | 3 | PS50004 | |
| Domain | PDZ | 9.00e-03 | 148 | 54 | 3 | SM00228 | |
| Domain | - | 9.00e-03 | 148 | 54 | 3 | 2.60.40.150 | |
| Domain | SANT | 9.20e-03 | 50 | 54 | 2 | SM00717 | |
| Domain | - | 9.34e-03 | 150 | 54 | 3 | 2.30.42.10 | |
| Domain | SANT/Myb | 9.92e-03 | 52 | 54 | 2 | IPR001005 | |
| Domain | SCAN | 1.14e-02 | 56 | 54 | 2 | SM00431 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 6.53e-05 | 6 | 30 | 2 | MM15534 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 9.13e-05 | 7 | 30 | 2 | M27807 | |
| Pubmed | NELFE SH3PXD2B KMT2D TCF20 PRRC2C AHNAK BAG3 YLPM1 NUFIP2 PDCD11 ACIN1 ARHGAP35 CHORDC1 TP53 | 1.22e-13 | 549 | 55 | 14 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NELFE PRRC2C AHNAK BAG3 YLPM1 NUFIP2 ACIN1 NUDCD3 ARHGAP35 TP53 AHNAK2 EFTUD2 | 1.99e-08 | 934 | 55 | 12 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NELFE FSIP2 SH3PXD2B TCF20 SASH1 PRRC2C AHNAK BAG3 PARD3B TP53 AHNAK2 | 8.90e-08 | 861 | 55 | 11 | 36931259 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NELFE SH3PXD2B HYOU1 PRRC2C AHNAK YLPM1 NUFIP2 ARHGAP35 WASHC2A AHNAK2 | 1.81e-07 | 724 | 55 | 10 | 36232890 |
| Pubmed | 2.13e-07 | 399 | 55 | 8 | 35987950 | ||
| Pubmed | 2.15e-07 | 267 | 55 | 7 | 33417871 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE RSBN1 TCF20 PRRC2C AHNAK YLPM1 NUFIP2 PDCD11 ACIN1 TP53 EFTUD2 | 2.48e-07 | 954 | 55 | 11 | 36373674 |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 4.74e-07 | 97 | 55 | 5 | 37151849 | |
| Pubmed | 8.08e-07 | 653 | 55 | 9 | 22586326 | ||
| Pubmed | Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. | 8.46e-07 | 109 | 55 | 5 | 29111324 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.11e-06 | 341 | 55 | 7 | 32971831 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SH3PXD2B HYOU1 AHNAK NAB2 BAG3 YLPM1 PDCD11 ACIN1 NUDCD3 CHORDC1 AHNAK2 EFTUD2 | 1.19e-06 | 1367 | 55 | 12 | 32687490 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.34e-06 | 220 | 55 | 6 | 35785414 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.54e-06 | 123 | 55 | 5 | 26912792 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32697937 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 15542853 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31537689 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 15007166 | ||
| Pubmed | Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. | 2.46e-06 | 2 | 55 | 2 | 16885345 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 35226388 | ||
| Pubmed | Regulation of p53 target gene expression by peptidylarginine deiminase 4. | 2.46e-06 | 2 | 55 | 2 | 18505818 | |
| Pubmed | An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression. | 2.46e-06 | 2 | 55 | 2 | 37140445 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32578139 | ||
| Pubmed | Molecular and cellular basis of mammary gland fibrosis and cancer risk. | 2.46e-06 | 2 | 55 | 2 | 30450584 | |
| Pubmed | Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. | 2.46e-06 | 2 | 55 | 2 | 22334079 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20833135 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32064880 | ||
| Pubmed | Telomere DNA Damage Signaling Regulates Prostate Cancer Tumorigenesis. | 2.46e-06 | 2 | 55 | 2 | 32467172 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NELFE TCF20 AHNAK BAG3 YLPM1 NUFIP2 PDCD11 ACIN1 ISG20L2 EFTUD2 | 3.03e-06 | 989 | 55 | 10 | 36424410 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.25e-06 | 774 | 55 | 9 | 15302935 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18451109 | ||
| Pubmed | Dysfunctional mammalian telomeres join with DNA double-strand breaks. | 7.36e-06 | 3 | 55 | 2 | 15010310 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 21454715 | ||
| Pubmed | Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. | 7.36e-06 | 3 | 55 | 2 | 20190809 | |
| Pubmed | MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. | 7.36e-06 | 3 | 55 | 2 | 26173586 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 21940993 | ||
| Pubmed | KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. | 7.36e-06 | 3 | 55 | 2 | 37142882 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27749841 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 25582503 | ||
| Pubmed | Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA. | 7.36e-06 | 3 | 55 | 2 | 18056407 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 28239143 | ||
| Pubmed | Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. | 7.36e-06 | 3 | 55 | 2 | 19843866 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 31123786 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 34232992 | ||
| Pubmed | KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer. | 7.36e-06 | 3 | 55 | 2 | 32243837 | |
| Pubmed | Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. | 7.36e-06 | 3 | 55 | 2 | 21057505 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 32988919 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 34645806 | ||
| Pubmed | Control of stereocilia length during development of hair bundles. | 1.47e-05 | 4 | 55 | 2 | 37011103 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 29126443 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 28428263 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 19058849 | ||
| Pubmed | KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. | 1.47e-05 | 4 | 55 | 2 | 36525973 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 27885802 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 17185750 | ||
| Pubmed | Role of 53BP1 oligomerization in regulating double-strand break repair. | 1.47e-05 | 4 | 55 | 2 | 23345425 | |
| Pubmed | TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer. | 1.47e-05 | 4 | 55 | 2 | 33941611 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 35100259 | ||
| Pubmed | Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. | 1.47e-05 | 4 | 55 | 2 | 20339076 | |
| Pubmed | 2.38e-05 | 216 | 55 | 5 | 31519766 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 20332152 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 33823136 | ||
| Pubmed | KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. | 2.45e-05 | 5 | 55 | 2 | 30905761 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 20505086 | ||
| Pubmed | DNA-damage response and repair activities at uncapped telomeres depend on RNF8. | 2.45e-05 | 5 | 55 | 2 | 21857671 | |
| Pubmed | 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. | 2.45e-05 | 5 | 55 | 2 | 18931659 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 31276534 | ||
| Pubmed | 3.49e-05 | 234 | 55 | 5 | 36243803 | ||
| Pubmed | 3.65e-05 | 1049 | 55 | 9 | 27880917 | ||
| Pubmed | DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. | 3.67e-05 | 6 | 55 | 2 | 15968270 | |
| Pubmed | p300-mediated acetylation of TRF2 is required for maintaining functional telomeres. | 3.67e-05 | 6 | 55 | 2 | 23307557 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 3.77e-05 | 807 | 55 | 8 | 30575818 | |
| Pubmed | 4.42e-05 | 407 | 55 | 6 | 12693553 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.58e-05 | 605 | 55 | 7 | 28977666 | |
| Pubmed | 4.88e-05 | 251 | 55 | 5 | 31076518 | ||
| Pubmed | NELFE RSBN1 PRRC2C AHNAK YLPM1 NUFIP2 PDCD11 ACIN1 ISG20L2 TP53 | 5.09e-05 | 1371 | 55 | 10 | 36244648 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 16962269 | ||
| Pubmed | Removal of shelterin reveals the telomere end-protection problem. | 5.13e-05 | 7 | 55 | 2 | 22556254 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 24323028 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 5.13e-05 | 7 | 55 | 2 | 23415230 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 21436032 | ||
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 13853422 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SH3PXD2B KMT2D AHNAK PDCD11 CARD10 ARHGAP35 WASHC2A ADAT1 AHNAK2 | 5.46e-05 | 1105 | 55 | 9 | 35748872 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 6.46e-05 | 639 | 55 | 7 | 23443559 | |
| Pubmed | 6.59e-05 | 641 | 55 | 7 | 36057605 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 7.15e-05 | 444 | 55 | 6 | 34795231 | |
| Pubmed | RSBN1 KMT2D TCF20 PRRC2C YLPM1 PDCD11 ISX ZFHX3 WASHC2A TP53 | 7.19e-05 | 1429 | 55 | 10 | 35140242 | |
| Pubmed | 7.54e-05 | 655 | 55 | 7 | 35819319 | ||
| Pubmed | HYOU1 PRRC2C AHNAK PCLO FBF1 YLPM1 ACIN1 ISG20L2 TERF2 FER1L6 | 7.75e-05 | 1442 | 55 | 10 | 35575683 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.59e-05 | 283 | 55 | 5 | 30585729 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 8.77e-05 | 54 | 55 | 3 | 25631074 | |
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 19339464 | ||
| Pubmed | 9.65e-05 | 469 | 55 | 6 | 27634302 | ||
| Pubmed | 1.00e-04 | 472 | 55 | 6 | 38943005 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.06e-04 | 477 | 55 | 6 | 31300519 | |
| Pubmed | 1.09e-04 | 298 | 55 | 5 | 30737378 | ||
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 26290144 | ||
| Pubmed | Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53. | 1.10e-04 | 10 | 55 | 2 | 33601405 | |
| Pubmed | 1.11e-04 | 156 | 55 | 4 | 32850835 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.17e-04 | 486 | 55 | 6 | 30940648 | |
| Interaction | NUP43 interactions | FSIP2 RSBN1 KMT2D TCF20 PRRC2C PDCD11 ACIN1 ZFHX3 TERF2 TP53 AHNAK2 | 8.09e-07 | 625 | 55 | 11 | int:NUP43 |
| Interaction | CHD4 interactions | NELFE TCF20 PRRC2C AHNAK NAB2 YLPM1 NUFIP2 PDCD11 ACIN1 ZFHX3 TP53 EFTUD2 | 6.63e-06 | 938 | 55 | 12 | int:CHD4 |
| Interaction | NAA40 interactions | NELFE PRRC2C AHNAK BAG3 YLPM1 NUFIP2 ACIN1 NUDCD3 ARHGAP35 TP53 AHNAK2 EFTUD2 | 1.01e-05 | 978 | 55 | 12 | int:NAA40 |
| Interaction | SMC5 interactions | NELFE RSBN1 TCF20 PRRC2C AHNAK YLPM1 NUFIP2 PDCD11 ACIN1 TERF2 TP53 EFTUD2 | 1.27e-05 | 1000 | 55 | 12 | int:SMC5 |
| Interaction | SUPT5H interactions | 1.40e-05 | 408 | 55 | 8 | int:SUPT5H | |
| Interaction | DIS3 interactions | 1.44e-05 | 194 | 55 | 6 | int:DIS3 | |
| Interaction | ANXA2 interactions | 1.69e-05 | 419 | 55 | 8 | int:ANXA2 | |
| Interaction | WWTR1 interactions | 1.78e-05 | 422 | 55 | 8 | int:WWTR1 | |
| Interaction | KBTBD4 interactions | 2.32e-05 | 316 | 55 | 7 | int:KBTBD4 | |
| Interaction | YAP1 interactions | NELFE KMT2D HYOU1 TCF20 PRRC2C AHNAK BAG3 YLPM1 NUFIP2 ACIN1 ARHGAP35 TP53 | 3.12e-05 | 1095 | 55 | 12 | int:YAP1 |
| Interaction | XRCC6 interactions | NELFE HYOU1 TCF20 YLPM1 ACIN1 IRF2 ZFHX3 CHORDC1 TERF2 TP53 EFTUD2 | 3.46e-05 | 928 | 55 | 11 | int:XRCC6 |
| Interaction | SUB1 interactions | 5.59e-05 | 247 | 55 | 6 | int:SUB1 | |
| Interaction | PSPC1 interactions | 7.30e-05 | 515 | 55 | 8 | int:PSPC1 | |
| Interaction | NPM1 interactions | NELFE RSBN1 PADI4 MICALL2 PRRC2C NUFIP2 CCDC190 PDCD11 ISG20L2 TP53 AHNAK2 EFTUD2 | 7.64e-05 | 1201 | 55 | 12 | int:NPM1 |
| Interaction | CEBPB interactions | NELFE KMT2D HYOU1 TCF20 PRRC2C AHNAK YLPM1 NUFIP2 ACIN1 IRF2 CHORDC1 TERF2 EFTUD2 | 1.05e-04 | 1443 | 55 | 13 | int:CEBPB |
| Interaction | ZNF24 interactions | 1.11e-04 | 174 | 55 | 5 | int:ZNF24 | |
| Interaction | TOP3B interactions | SH3PXD2B KMT2D HYOU1 AHNAK NUFIP2 PDCD11 ACIN1 CARD10 ARHGAP35 WASHC2A ADAT1 TP53 AHNAK2 | 1.26e-04 | 1470 | 55 | 13 | int:TOP3B |
| Interaction | FKBP5 interactions | 1.27e-04 | 414 | 55 | 7 | int:FKBP5 | |
| Interaction | DDX21 interactions | 1.29e-04 | 718 | 55 | 9 | int:DDX21 | |
| Interaction | PLOD3 interactions | 1.41e-04 | 183 | 55 | 5 | int:PLOD3 | |
| Interaction | SENP3 interactions | 1.66e-04 | 301 | 55 | 6 | int:SENP3 | |
| Interaction | SIRT7 interactions | 1.68e-04 | 744 | 55 | 9 | int:SIRT7 | |
| Interaction | USP7 interactions | RSBN1 PADI4 KMT2D TCF20 AHNAK TCEAL2 FBF1 YLPM1 IRF2 TP53 FER1L6 EFTUD2 | 1.78e-04 | 1313 | 55 | 12 | int:USP7 |
| Interaction | KDM1A interactions | KMT2D ZNHIT6 TCF20 AHNAK BAG3 ZFHX3 CARD10 NUDCD3 TP53 EFTUD2 | 2.03e-04 | 941 | 55 | 10 | int:KDM1A |
| Interaction | MACROD2 interactions | 2.03e-04 | 8 | 55 | 2 | int:MACROD2 | |
| Interaction | PEF1 interactions | 2.16e-04 | 108 | 55 | 4 | int:PEF1 | |
| Interaction | DPY30 interactions | 2.33e-04 | 204 | 55 | 5 | int:DPY30 | |
| Cytoband | 1q23.3 | 2.88e-05 | 49 | 55 | 3 | 1q23.3 | |
| Cytoband | 1p36.13 | 2.08e-03 | 56 | 55 | 2 | 1p36.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 2.56e-03 | 226 | 55 | 3 | chr1q23 | |
| GeneFamily | PDZ domain containing | 2.29e-04 | 152 | 36 | 4 | 1220 | |
| GeneFamily | Heat shock 70kDa proteins | 5.14e-04 | 17 | 36 | 2 | 583 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.98e-03 | 53 | 36 | 2 | 532 | |
| Coexpression | LAU_APOPTOSIS_CDKN2A_UP | 5.46e-06 | 55 | 55 | 4 | M1411 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.94e-07 | 142 | 55 | 5 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.94e-07 | 142 | 55 | 5 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.37e-06 | 186 | 55 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-06 | 197 | 55 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-06 | 200 | 55 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-06 | 200 | 55 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-05 | 142 | 55 | 4 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 145 | 55 | 4 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-05 | 172 | 55 | 4 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 190 | 55 | 4 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 196 | 55 | 4 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 196 | 55 | 4 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 196 | 55 | 4 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 197 | 55 | 4 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-04 | 197 | 55 | 4 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.04e-04 | 198 | 55 | 4 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 200 | 55 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | hypertrophic cardiomyopathy | 2.31e-05 | 92 | 53 | 4 | EFO_0000538 | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.13e-04 | 9 | 53 | 2 | 114550 | |
| Disease | Adult Hepatocellular Carcinoma | 1.13e-04 | 9 | 53 | 2 | C0279607 | |
| Disease | Hepatocellular carcinoma | 1.13e-04 | 9 | 53 | 2 | cv:C2239176 | |
| Disease | glioblastoma (implicated_via_orthology) | 1.13e-04 | 9 | 53 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.72e-04 | 11 | 53 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.17e-04 | 181 | 53 | 4 | DOID:684 (is_implicated_in) | |
| Disease | heart failure | 3.45e-04 | 185 | 53 | 4 | EFO_0003144 | |
| Disease | T-Cell Lymphoma | 3.74e-04 | 16 | 53 | 2 | C0079772 | |
| Disease | sphingomyelin 14:0 measurement | 4.23e-04 | 17 | 53 | 2 | EFO_0010390 | |
| Disease | information processing speed | 4.87e-04 | 85 | 53 | 3 | EFO_0004363 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 5.31e-04 | 19 | 53 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | hearing impairment | 7.38e-04 | 98 | 53 | 3 | C1384666 | |
| Disease | Colorectal cancer | 1.08e-03 | 27 | 53 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 1.08e-03 | 27 | 53 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 1.08e-03 | 27 | 53 | 2 | cv:C0009404 | |
| Disease | Sezary Syndrome | 1.08e-03 | 27 | 53 | 2 | C0036920 | |
| Disease | suicidal ideation | 1.25e-03 | 29 | 53 | 2 | EFO_0004320 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPAEHEVKKVTLGD | 961 | Q9UKV3 | |
| GPPPGAEEKEKEKEK | 256 | Q9BWT7 | |
| PDVDLHLKGPKVKGD | 1656 | Q09666 | |
| DIDIHGPEGKLKGPK | 4566 | Q09666 | |
| QEHPPGKQEKTEKHP | 251 | Q9ULG3 | |
| KPPVELKGPDGIHVV | 3271 | Q9H251 | |
| GIRLPKKGKPEPNHE | 16 | Q9BUB4 | |
| GLEKPPKDQPQEGRK | 66 | Q2M1V0 | |
| HTGKHQPGVDKPDPK | 61 | P14316 | |
| PGVVVDIAHGPPAKK | 46 | Q9UM07 | |
| DGVLKTKVPPPVHGK | 311 | Q8TEW8 | |
| TLEGKLKDPEKGPVP | 91 | P18615 | |
| GHQEVEKVQPPGPVK | 126 | Q8IVD9 | |
| LKPNHKKEPGLFEPD | 1796 | Q9UKN7 | |
| HPEELGGPPLKKLKQ | 366 | Q15742 | |
| DDVPKLQPHPGLEKK | 216 | Q14165 | |
| GKGKQPKEDRPEHYP | 1741 | Q6ZU64 | |
| LKPDGNTGKQIPPKH | 216 | Q86UF4 | |
| ESPIKIVPHVGKKPV | 6516 | Q5CZC0 | |
| EEEKKPHLQGKPGRP | 696 | Q8IY33 | |
| VQKEQGKPEGIIKPP | 196 | Q9Y6V0 | |
| HGKEEIKVIPTPPAD | 326 | P51160 | |
| GEPPPKKALEGNAKH | 11 | Q9H9L3 | |
| VEGKHPPEKLLVKDG | 546 | O43301 | |
| KKGEPHHELPPGSTK | 291 | P04637 | |
| KAAKDPGKGELPNHP | 101 | Q8TES7 | |
| GVAPAPEGEKKQKPA | 676 | Q9Y4L1 | |
| EPEKKDKPHQPLELP | 1621 | Q8N3K9 | |
| DTKVKEEPPINHPVG | 196 | Q9NWK9 | |
| PEILGKPHDPDSQKK | 111 | Q5VTH2 | |
| VKGEHKEFPLPPVPK | 261 | Q9UQ10 | |
| GEAEAPPKHPGVLKV | 411 | O95817 | |
| HTPVAQEPPKDGKPK | 1171 | Q2WGJ9 | |
| EEPDKEGKEKPHAGV | 66 | Q5VWQ0 | |
| EPVPGKKLPTTGEVH | 781 | Q9HCH5 | |
| EVPEAKGKPVKAAPV | 131 | Q8NEQ6 | |
| PVENKEHKPGPIGKE | 2106 | Q9Y520 | |
| PGPAPENEDGLVKVK | 6 | Q96JS3 | |
| GQHLPKNKRPKEPGE | 21 | Q15198 | |
| VKPKPPVHFEITKGD | 1041 | Q9NRY4 | |
| VPEGAGPKVHLPKVE | 906 | Q8IVF2 | |
| KGRHNSEKPPEPVKP | 61 | Q9UHD1 | |
| PEPKKEPAGHSQKKG | 616 | Q14690 | |
| GPGKHAEKELCKDPP | 231 | P17040 | |
| GAEGSPKAQPKPLKH | 61 | Q7Z417 | |
| PEDLNPPKEEHIGKK | 126 | A1X283 | |
| QPDPEHLDKPKLKAG | 491 | O94885 | |
| GKIDNEEQPPHEGKP | 16 | Q9H3H9 | |
| IPEGSADGEPKPKKQ | 1566 | Q9UGU0 | |
| HKKGPVVAKDTPEPV | 316 | P49750 | |
| QKEVGKGRDPDAHPK | 821 | Q641Q2 | |
| DPGLKKHQEEPEKPS | 121 | Q9Y2Y4 | |
| QHIPSPKVGAKPKIE | 436 | Q15029 | |
| GKEDKQPAPGPVEKP | 296 | Q15554 | |
| AHKGKGEPLPVPKKE | 3246 | Q15911 | |
| KLKEPQPQDHKPGLG | 121 | Q6UXU0 | |
| PEVKPKVEEGGRHPS | 3116 | O14686 |